Latest Articles

2020/09/29 - Media Coverage

Lend-Rx Technology team is proud to have his Lead Data Scientist, Philippe Very associated with Victor Bouvier's (datascientist at Sidetrade) break through Machine Learning paper (https://lnkd.in/gmjnJqf ) which has just received the best machine learning paper award at ECML-PKDD 2020.#machinelearning#ECML-PKDD 2020

2020/07/31 - Lend-Rx in the press

WatersTechnology.com
Vaccine Tracking Data—The Next Big Alt Dataset - WatersTechnology.com Investment firms and vendors are searching for signals in healthcare and pharmaceutical data in a bid to get a leg up on a Covid-19 vaccine.

2019/11/05 - EagleAlpha

Lend-Rx Technology, an advanced, AI-driven financial information provider on the healthcare sector, and Eagle Alpha, the pioneer connecting the universe of alternative data, today announced the addition of Lend-Rx Technology data to Eagle Alpha’s library of alternative data supplied to asset managers, private equity professionals and corporate enterprises. Lend-Rx Technology will make available its data from its AI-powered platform that processes and analyzes million texts globally on over 8000 therapeutics to identify explicit cause-and-effect statements. Lend-Rx Technology proprietary algorithms aggregates the knowledge of millions of authors into a single deductive system, allowing portfolio managers, analysts and corporates to understand the KPIs, events, trends in the therapeutics space. Data on therapeutics mapped to over 3000 companies are delivered though weekly datasets. Established in 2012, Eagle Alpha is a pioneer in the alternative data universe. The firm was one of the first to understand the value of non-traditional data sources and now has access to nearly 1,500  global datasets, providing knowledge and solutions to top buy-side clients and a variety of leading businesses.  [Firms interested in learning more about receiving Lend-Rx Datasets through Eagle Alpha can contact at  info@eaglealpha.com.]

2019/10/15 - Neudata

Lend-Rx Technology, an advanced, AI-driven financial information provider on the healthcare sector, and Neudata,  – the industry-leading alternative data scouting and research platform, Neudata Scout today announced the addition of Lend-Rx Technology data to Neudata Scout library of alternative data supplied to asset managers, private equity professionals and corporate enterprises. Lend-Rx Technology AI-powered platform processes and analyzes million texts globally on over 8000 therapeutics to identify explicit cause-and-effect statements. Lend-Rx Technology proprietary algorithms aggregates the knowledge of millions of authors into a single deductive system, allowing portfolio managers, analysts and corporates to understand the KPIs, events, trends in the therapeutics space. Data on therapeutics mapped to over 3000 companies are delivered though weekly datasets. Neudata is the industry’s only objective and neutral data scouting FinTech firm and is dedicated to finding alternative data for the world’s leading asset managers, private equity/venture capital firms and corporations. Neudata's Software as a Service (SaaS) catalogue of 5,700+ dataset reports provides tools for users to easily search, source, manage, and compare data, while leveraging real-time insights from its team of expert analysts based in London, New York and Shanghai.

2019/05/14 - Wilco

Lend-Rx Technology, an advanced, AI-driven financial information provider on the healthcare sector has been selected to join Wilco innovation accelerator. Lend-Rx Technology AI-powered platform processes and analyzes million texts globally on over 8000 therapeutics to identify explicit cause-and-effect statements. Lend-Rx Technology proprietary algorithms aggregates the knowledge of millions of authors into a single deductive system, allowing portfolio managers, analysts and corporates to understand the KPIs, events, trends in the therapeutics space. Data on therapeutics mapped to over 3000 companies are delivered though weekly datasets. WILCO is an innovation accelerator that supports the growth of startups up to their first million euros and the transformation of large companies. A major player in the acceleration of startups in France (350 startups accelerated continuously), and based on a non-intrusive business model (no equity investment), WILCO is supported by more than 30 corporate partners (Axa, EDF, Bouygues Telecom, Air Liquide, etc.) and by public players (IdF region, Europe, etc.)